Company Description
Xanodyne Pharmaceuticals hopes that its medicines can be the X factor needed to treat ailments. The company develops and...
Key Xanodyne Pharmaceuticals Financials
| Company Type | Private - NASDAQ (GM): XANO Proposed Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2006 Sales (mil.) | $66.9 |
| 2006 Employees | 177 |
More Xanodyne Pharmaceuticals Financials (4 pages)
Latest Xanodyne Pharmaceuticals Jobs jobs by Indeed
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs....
Read more about Xanodyne Pharmaceuticals's competition across multiple industries
Top Xanodyne Pharmaceuticals Competitors
Editor-Selected Competitor List For Xanodyne Pharmaceuticals
Sponsored Links
The Business DirectoryTrading Toolbox
Xanodyne Pharmaceuticals Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| EVP Business Development and CFO | Stephen A. Stamp | Network | E-mail |
| VP Marketing | Daniel W. (Dan) Docherty | Network | E-mail |
| President and CEO | Greg Flexter | Network | E-mail |
More Xanodyne Pharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Xanodyne Pharmaceuticals News
- [DIAG]-People in Places [AHC Newsletters] (03 Jul 2008 00:01:00 EDT)
- [MDW]-People in Places [AHC Newsletters] (01 Jul 2008 00:01:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.